PDGFRB and Hepatic fibrosis: TGFRB activation leads to activation of SMAD signaling pathways (47, 48), PDGFR cross-linking activates the STAT3 pathway (49, 50), and both of these pathways have well-known roles in promoting hepatic fibrosis (50).